【China Chemical】Announcement of the Board's Approval of the Q1 2026 Individual Financial Report
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
China Chemical & Pharmaceutical has announced that its Board of Directors approved the individual financial report for Q1 2026. The report states operating revenue of NT$519.337 million, net profit attributable to parent company owners of NT$35.899 million, and basic EPS of NT$0.28.